Henzo Kenya is a patient support group made up of CML, GIST and recently added osteosarcoma patients. The need to support each other as patients inspired the great idea that is Henzo Kenya. Henzo [...]
Is pregnancy for me?, is a common question among GIST patients. At present there isn't a lot of data on pregnancy and GIST. The prescription information on Gleevec clearly warns of risks if a [...]
On Saturday December 15, 2012, a group of CML and GIST patients got together to summarize activities done during 2012, and celebrate the end of the year.
A study of newly diagnosed CML patients concentrated on OCT-1 activity as a predictor of molecular response and progression-free survival (PFS) treated with imatinib.
This month, Novartis Pharmaceuticals (maker of Gleevec) launched a new website designed to help optimize the outcome of GIST patients taking Gleevec. Some of the featured content is about blood level testing for GIST. In addition, the website prominently links to the Avantix labs website (www.bloodleveltesting.com) for testing Gleevec blood levels in CML and GIST.